GoodRx Offers Largest Appointment Tracker for COVID-19 Vaccines
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Company offers vaccine inventory and appointment information at over 50,000 sites across the nation
SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx (Nasdaq: GDRX), America’s leading resource for healthcare savings, is helping consumers navigate the roll-out of the COVID-19 vaccine with the launch of its Vaccine Guide.
In conjunction with the CDC, VaccineFinder and other partners, GoodRx is tracking daily vaccine inventory and available appointments at more than 50,000 sites across the nation, including thousands of America’s 70,000 pharmacies, state and local government mega-sites, hospitals, and clinics. Through the Vaccine Guide, consumers can browse available appointments by state, vaccination site, or pharmacy, and determine what type of vaccine is available at a specific location.
“We founded GoodRx to help guide people through the complex healthcare system, and nothing has been more confusing or overwhelming than the roll-out of the COVID-19 vaccine,” said co-CEO and co-founder Doug Hirsch. “With the Vaccine Guide, we have created a site where available information is organized and centralized in one place, and then delivered directly to consumers in a digestible manner. Our hope is that it will help streamline available information so Americans easily find a vaccination appointment near them as soon as they are eligible.”
A team of analysts track vaccine updates in real-time and update the site as new information and data becomes available. This includes updates to eligibility, inventory and appointments, as well as emergency use authorizations for new vaccines. Consumers can sign up for text message alerts to stay informed about important local news and eligibility changes. More than 1.8 million Americans have signed up so far.
For those seeking to learn more about COVID-19, GoodRx also provides a comprehensive resource hub that outlines information around transmission, symptoms, research, treatment, and medication. You can also find in-depth information around cost, effectiveness, side effects, and state requirements.
Information is curated across all 50 states, D.C., and Puerto Rico.
GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. We have helped Americans save over $25 billion since 2011 and are the #1 most downloaded medical app over the last three years.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our provision of information related to the coronavirus vaccine roll-out. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed under the caption “Risk Factors” in GoodRx’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020,, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Hartford (HIG) Reports Q1 EPS of $0.56; Rejects Additional Proposal from Chubb (CB), Raises Buyback
- Inspire Charter Academy Notice of a Regular Meeting of the Board of Directors
- Aveanna Healthcare Holdings (AVAH) Announces Proposed 38.236M Share IPO at $16-$18/Sh